ELAN Stock - Elanco Animal Health Incorporated
Unlock GoAI Insights for ELAN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.44B | $4.42B | $4.41B | $4.76B | $3.27B |
| Gross Profit | $1.91B | $1.94B | $1.97B | $2.08B | $1.25B |
| Gross Margin | 43.0% | 43.9% | 44.7% | 43.6% | 38.1% |
| Operating Income | $251.00M | $326.00M | $384.00M | $304.00M | $-76,800,000 |
| Net Income | $338.00M | $-1,231,000,000 | $-78,000,000 | $-483,000,000 | $-560,100,000 |
| Net Margin | 7.6% | -27.9% | -1.8% | -10.1% | -17.1% |
| EPS | $0.68 | $-2.50 | $-0.15 | $-0.97 | $-1.27 |
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Visit WebsiteEarnings History & Surprises
ELANEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 24, 2026 | $0.11 | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.13 | $0.19 | +46.2% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.20 | $0.26 | +30.0% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $0.31 | $0.37 | +19.4% | ✓ BEAT |
Q1 2025 | Feb 25, 2025 | $0.16 | $0.14 | -12.5% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $0.12 | $0.13 | +8.3% | ✓ BEAT |
Q3 2024 | Aug 8, 2024 | $0.24 | $0.30 | +25.0% | ✓ BEAT |
Q2 2024 | May 8, 2024 | $0.27 | $0.34 | +24.1% | ✓ BEAT |
Q1 2024 | Feb 26, 2024 | $0.10 | $0.08 | -20.0% | ✗ MISS |
Q4 2023 | Nov 7, 2023 | $0.12 | $0.18 | +50.0% | ✓ BEAT |
Q3 2023 | Aug 7, 2023 | $0.05 | $0.18 | +260.0% | ✓ BEAT |
Q2 2023 | May 9, 2023 | $0.29 | $0.45 | +55.2% | ✓ BEAT |
Q1 2023 | Feb 21, 2023 | $0.13 | $0.19 | +46.2% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $0.16 | $0.20 | +25.0% | ✓ BEAT |
Q3 2022 | Aug 8, 2022 | $0.26 | $0.36 | +38.5% | ✓ BEAT |
Q2 2022 | May 9, 2022 | $0.35 | $0.36 | +2.9% | ✓ BEAT |
Q1 2022 | Feb 24, 2022 | $0.17 | $0.21 | +23.5% | ✓ BEAT |
Q4 2021 | Nov 5, 2021 | $0.17 | $0.19 | +11.8% | ✓ BEAT |
Q3 2021 | Aug 9, 2021 | $0.26 | $0.28 | +7.7% | ✓ BEAT |
Latest News
Frequently Asked Questions about ELAN
What is ELAN's current stock price?
What is the analyst price target for ELAN?
What sector is Elanco Animal Health Incorporated in?
What is ELAN's market cap?
Does ELAN pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ELAN for comparison